Zobrazeno 1 - 10
of 2 420
pro vyhledávání: '"radiogenomics"'
Autor:
Gagandeep Singh, Annie Singh, Joseph Bae, Sunil Manjila, Vadim Spektor, Prateek Prasanna, Angela Lignelli
Publikováno v:
Cancer Imaging, Vol 24, Iss 1, Pp 1-39 (2024)
Abstract Gliomas and Glioblastomas represent a significant portion of central nervous system (CNS) tumors associated with high mortality rates and variable prognosis. In 2021, the World Health Organization (WHO) updated its Glioma classification crit
Externí odkaz:
https://doaj.org/article/b5f96079a9f049a2b954d3eb3628f6b8
Autor:
E. V. Kondratyev, A. D. Smirnova, G. G. Karmazanovsky, A. S. Tyan, N. N. Britskaya, M. G. Efanov, B. N. Gurmikov
Publikováno v:
Issledovaniâ i Praktika v Medicine, Vol 11, Iss 3, Pp 65-75 (2024)
Purpose of the study. To study the CT semiotics of intrahepatic cholangiocarcinoma (ICC) to determine the prognostic markers of recurrence. To analyze the association between CT characteristics of ICC and mutations in IDH1/2, MET, KRAS, BRAF, ERBB2,
Externí odkaz:
https://doaj.org/article/aa0941d6a0b243bdb046a329ab0b63d2
Autor:
Hao Yang, Xinyi Gou, Caizhen Feng, Yuanyuan Zhang, Boshi Sun, Peng Peng, Yi Wang, Nan Hong, Yingjiang Ye, Jin Cheng, Bo Gao
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-15 (2024)
Abstract Background CT-detected Extramural venous invasion (EMVI) is known as an independent risk factor for distant metastasis in patients with advanced gastric cancer (GC). However, the molecular basis is not clear. In colorectal cancer, M2 macroph
Externí odkaz:
https://doaj.org/article/067d00e89e9944889509cf912282f45f
Autor:
Zhuokai Zhuang, Jinxin Lin, Zixiao Wan, Jingrong Weng, Ze Yuan, Yumo Xie, Zongchao Liu, Peiyi Xie, Siyue Mao, Zongming Wang, Xiaolin Wang, Meijin Huang, Yanxin Luo, Huichuan Yu
Publikováno v:
BMC Medicine, Vol 22, Iss 1, Pp 1-13 (2024)
Abstract Background The radiogenomic analysis has provided valuable imaging biomarkers with biological insights for gliomas. The radiogenomic markers for molecular profile such as DNA methylation remain to be uncovered to assist the molecular diagnos
Externí odkaz:
https://doaj.org/article/f55e31d92a884c60a69b28a048c57258
Publikováno v:
Biomarker Research, Vol 12, Iss 1, Pp 1-21 (2024)
Abstract Background High-grade serous ovarian cancer (HGSOC), which is known for its heterogeneity, high recurrence rate, and metastasis, is often diagnosed after being dispersed in several sites, with about 80% of patients experiencing recurrence. D
Externí odkaz:
https://doaj.org/article/ada281d7158342069aea4fc13e5a9c29
Publikováno v:
Cancer Imaging, Vol 24, Iss 1, Pp 1-14 (2024)
Abstract Background Triple-negative breast cancer (TNBC) is highly heterogeneous, resulting in different responses to neoadjuvant chemotherapy (NAC) and prognoses among patients. This study sought to characterize the heterogeneity of TNBC on MRI and
Externí odkaz:
https://doaj.org/article/523ed13c920f4affab5ef527bbc128fe
Autor:
N. E. Maslov, G. E. Trufanov, V. M. Moiseenko, D. A. Valenkova, A. Yu. Efimtsev, N. A. Plakhotina, A. S. Sidorina
Publikováno v:
Вестник медицинского института «Реавиз»: Реабилитация, врач и здоровье, Vol 14, Iss 1, Pp 168-176 (2024)
Introduction. Radiomics is a rapidly developing field in oncology visualization aimed at searching for prognostically effective imaging features associated with specific genetic events that determine various characteristics of the disease course. Acc
Externí odkaz:
https://doaj.org/article/b0ed279d05db428bb236f5c98eaf42e1
Publikováno v:
Current Issues in Molecular Biology, Vol 46, Iss 4, Pp 3236-3250 (2024)
Radiogenomics, a burgeoning field in biomedical research, explores the correlation between imaging features and genomic data, aiming to link macroscopic manifestations with molecular characteristics. In this review, we examine existing radiogenomics
Externí odkaz:
https://doaj.org/article/7bfd5dcc57314eb6b260eb575047e010
Publikováno v:
iRADIOLOGY, Vol 2, Iss 2, Pp 113-127 (2024)
Abstract Head and neck cancer is a significant threat to human health and is characterized by high 5‐year morbidity and mortality rates. Addressing this challenge requires the application of precision medicine, but the inherent heterogeneity of hea
Externí odkaz:
https://doaj.org/article/fb9217fea5e14a3caa566272536e33d5
Publikováno v:
MedComm, Vol 5, Iss 9, Pp n/a-n/a (2024)
Abstract Genomics allows the tracing of origin and evolution of cancer at molecular scale and underpin modern cancer diagnosis and treatment systems. Yet, molecular biomarker‐guided clinical decision‐making encounters major challenges in the real
Externí odkaz:
https://doaj.org/article/0c68b54d8f9c4e11854d773d8de68b59